Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
Intervalo de ano de publicação
1.
Korean J Gastroenterol ; 44(6): 321-7, 2004 Dec.
Artigo em Coreano | MEDLINE | ID: mdl-15665576

RESUMO

BACKGROUND/AIMS: Various etiologies and diseases may be related to erosions and/or small ulcers without gross inflammatory changes in the surrounding mucosa found in the colon and terminal ileum during colonoscopy. However, studies on follow-up of these lesions are rare. Thus, we investigated the clinical significance of these lesions and their characteristics helpful for differential diagnosis. METHODS: We reviewed the data of 183 patients with colonoscopically observed erosive or small ulcerative lesions (<2 cm), and analyzed them according to the location, number, and size of lesions, histopathologic findings, chief complaints, laboratory findings, changes of symptoms, and changes in lesions during 4-12 week follow-up period. RESULTS: Histopathologic findings of these lesions included acute nonspecific inflammation, chronic nonspecific inflammation, Crohn's disease, tuberculous colitis, ischemic colitis, Behcet's disease, cytomegalovirus infection, eosinophilic colitis, ulcerative colitis or pseudomembranous colitis, but most of them were nonspecific (84%). In patients with nonspecific inflammation, histopathologic findings, symptoms, location and multiplicity of the lesions were not prognostic factors for the persistency of symptoms and lesions during follow-up period. Two patients with acute inflammation, who showed no improvement in symptoms and lesions, were later diagnosed as Crohn's disease. CONCLUSIONS: Erosive or small ulcerative lesions without macroscopic inflammatory changes in the surrounding mucosa during colonoscopy, are mainly nonspecific. However, careful follow-up is required when the symptoms and/or lesions are not improved.


Assuntos
Colo/patologia , Íleo/patologia , Enteropatias/diagnóstico , Adolescente , Adulto , Idoso , Colonoscopia , Feminino , Humanos , Enteropatias/patologia , Masculino , Pessoa de Meia-Idade , Úlcera/patologia
2.
Taehan Kan Hakhoe Chi ; 8(3): 317-20, 2002 Sep.
Artigo em Coreano | MEDLINE | ID: mdl-12499790

RESUMO

Orlistat(Xenical(R), Roche) is considered a safe and effective drug to treat obesity by reduced absorption of 30% digested fat. To date, no serious adverse effects affecting the liver have been published except a case of subacute hepatic failure leading to liver transplantation in a young women with moderate obesity treated with orlistat. We report a case of acute cholestatic hepatitis in a young woman with moderate obesity treated with orlistat: a 33-year-old female admitted for the evaluation of jaundice. Abdominal ultrasonography, ERCP, routine chemistry, viral markers, and a fine needle biopsy of liver were performed. Microscopic findings of the liver biopsy specimen were compatible with acute cholestatic hepatitis. After steroid therapy, liver function was improved.


Assuntos
Fármacos Antiobesidade/efeitos adversos , Doença Hepática Induzida por Substâncias e Drogas/diagnóstico , Colestase/induzido quimicamente , Lactonas/efeitos adversos , Doença Aguda , Adulto , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Colestase/diagnóstico , Feminino , Humanos , Lipase/antagonistas & inibidores , Orlistate
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA